Prostate cancer news reports: Sunday, January 17, 2010

Posted on January 17, 2010 by Sitemaster

In today’s news reports we address recent publications on: The GEMCaP biomarkers and prediction of prostate cancer recurrence post-surgery Biopsy Gleason score under-staging and active surveillance The value of exercise during radiotherapy Impact of type of surgery on post-surgical continence at 1 year

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , , | 3 Comments »

New review of biomarkers for prostate cancer detection

Posted on January 9, 2010 by Sitemaster

Nogueira et al. have just published a new “mini-review” in BJU International that addresses the potential roles of current and “future” biomarkers that may have relevance to prostate cancer detection.

Filed under: Diagnosis, Risk | Tagged: , | Leave a Comment »

Prostate cancer news reports: Friday, June 5, 2009

Posted on June 5, 2009 by Sitemaster

Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles: 20 years of experience with the PSA test in assessment of risk for prostate cancer Biomarkers in the assessment of future risk for prostate cancer Treatment choice, outcome, and quality of life [...]

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , , , , , | Leave a Comment »

The clinical relevance of new biomarkers is tricky

Posted on May 5, 2009 by Sitemaster

Assiduous readers of this blog will have noted that there are relatively frequent mentions of “new” biomarkers that may have potential as indicators of the aggressiveness of prostate cancer — but that in most cases those biomarkers are never heard of again.

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Risk | Tagged: | 1 Comment »

The prostate cancer news report: Tuesday, May 5, 2009

Posted on May 5, 2009 by Sitemaster

We are returning to “normal” today with the standard “news reports.” Today’s items deal with: Evolving biomarkers and new tests and their future application MRI in diagnosis, staging, and prognosis of prostate cancer Intraprostatic injection of LHRH agonists and antagonists: is it viable? Gefitinib in HRPC: no evident impact on quality of life

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , | 2 Comments »

The Friday news reports (Part B): February 13, 2009

Posted on February 13, 2009 by Sitemaster

The second set of reports in today’s news commentaries encompasses new nomograms, possible new biomarkers, a specific subtype of prostate cancer, and the “hedgehog” signaling pathway.

Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , | Leave a Comment »

The weekend prostate cancer news: October 25, 2008

Posted on October 25, 2008 by Sitemaster

Some interesting new reports today include: An update on the Prostate Cancer Prevention Trial Early data on the potential of a traditional Chinese herbal medication Predictive value of PSA velocity in management of low-risk patients with low-dose brachytherapy Reviews of emerging biomarkers and the role(s) of MRI

Filed under: Diagnosis, Drugs in development, Management, Prevention | Tagged: , , , , , , | Leave a Comment »

Prostate cancer reports from ASTRO, no. 2

Posted on September 23, 2008 by Sitemaster

Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), being held in Boston, are kindly provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan. Most of the prostate cancer data presented in today’s scientific sessions were from retrospective reviews and the afternoon genitourinary session [...]

Filed under: Management, Treatment | Tagged: , , | Leave a Comment »

Follow

Get every new post delivered to your Inbox.

Join 269 other followers